ID ABCC9_MOUSE Reviewed; 1546 AA. AC P70170; O08902; O08920; P70171; DT 26-SEP-2001, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1999, sequence version 2. DT 24-JAN-2024, entry version 187. DE RecName: Full=ATP-binding cassette sub-family C member 9; DE AltName: Full=Sulfonylurea receptor 2; GN Name=Abcc9; Synonyms=Sur2; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS SUR2A AND SUR2B). RC TISSUE=Heart; RX PubMed=8798681; DOI=10.1074/jbc.271.40.24321; RA Isomoto S., Kondo C., Yamada M., Matsumoto S., Higashiguchi O., Horio Y., RA Matsuzawa Y., Kurachi Y.; RT "A novel sulfonylurea receptor forms with BIR (Kir6.2) a smooth muscle type RT ATP-sensitive K+ channel."; RL J. Biol. Chem. 271:24321-24324(1996). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS SUR2A AND SUR2C). RX PubMed=8826984; DOI=10.2337/diab.45.10.1439; RA Chutkow W.A., Simon M.C., Le Beau M.M., Burant C.F.; RT "Cloning, tissue expression, and chromosomal localization of SUR2, the RT putative drug-binding subunit of cardiac, skeletal muscle, and vascular RT KATP channels."; RL Diabetes 45:1439-1445(1996). RN [3] RP PROTEIN SEQUENCE OF 493-498, AND IDENTIFICATION BY MASS SPECTROMETRY. RC STRAIN=OF1; TISSUE=Hippocampus; RA Lubec G., Sunyer B., Chen W.-Q.; RL Submitted (JAN-2009) to UniProtKB. RN [4] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brown adipose tissue, Heart, and Spleen; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). CC -!- FUNCTION: Subunit of ATP-sensitive potassium channels (KATP). Can form CC cardiac and smooth muscle-type KATP channels with KCNJ11. KCNJ11 forms CC the channel pore while ABCC9 is required for activation and regulation. CC -!- SUBUNIT: Interacts with KCNJ11. CC -!- SUBCELLULAR LOCATION: Membrane {ECO:0000255|PROSITE-ProRule:PRU00441}; CC Multi-pass membrane protein {ECO:0000255|PROSITE-ProRule:PRU00441}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=3; CC Name=SUR2A; CC IsoId=P70170-1; Sequence=Displayed; CC Name=SUR2B; CC IsoId=P70170-2; Sequence=VSP_000060; CC Name=SUR2C; CC IsoId=P70170-3; Sequence=VSP_000059; CC -!- TISSUE SPECIFICITY: Isoforms SUR2A and SUR2B are found in cerebellum, CC eye, atrium, ventricle, urinary bladder and skeletal muscle. Isoform CC SUR2B is also found in forebrain, liver, lung, pancreas, kidney, CC spleen, stomach, small intestine, colon, uterus, ovary and fat tissue. CC Isoform SUR2C is expressed exclusively in the heart. CC -!- SIMILARITY: Belongs to the ABC transporter superfamily. ABCC family. CC Conjugate transporter (TC 3.A.1.208) subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; D86037; BAA12969.2; -; mRNA. DR EMBL; D86038; BAA12970.2; -; mRNA. DR EMBL; AF003531; AAB58753.1; -; mRNA. DR EMBL; U97066; AAB58701.1; -; mRNA. DR CCDS; CCDS39696.1; -. [P70170-2] DR CCDS; CCDS39697.1; -. [P70170-3] DR CCDS; CCDS39699.1; -. [P70170-1] DR PIR; T42711; T42711. DR PIR; T42728; T42728. DR RefSeq; NP_001038185.1; NM_001044720.1. DR RefSeq; NP_035641.1; NM_011511.2. [P70170-2] DR RefSeq; NP_066378.1; NM_021041.2. [P70170-1] DR RefSeq; NP_066379.2; NM_021042.2. [P70170-3] DR RefSeq; XP_006507011.1; XM_006506948.3. DR RefSeq; XP_006507012.1; XM_006506949.3. [P70170-2] DR RefSeq; XP_006507013.1; XM_006506950.3. [P70170-2] DR RefSeq; XP_006507014.1; XM_006506951.3. [P70170-2] DR AlphaFoldDB; P70170; -. DR SMR; P70170; -. DR BioGRID; 203578; 5. DR ComplexPortal; CPX-196; Inward rectifying potassium channel complex, Kir6.2-SUR2A. [P70170-1] DR ComplexPortal; CPX-198; Inward rectifying potassium channel complex, Kir6.2-SUR2B. [P70170-2] DR CORUM; P70170; -. DR STRING; 10090.ENSMUSP00000098390; -. DR GlyCosmos; P70170; 2 sites, No reported glycans. DR GlyGen; P70170; 2 sites. DR iPTMnet; P70170; -. DR PhosphoSitePlus; P70170; -. DR EPD; P70170; -. DR jPOST; P70170; -. DR MaxQB; P70170; -. DR PaxDb; 10090-ENSMUSP00000084805; -. DR ProteomicsDB; 296471; -. [P70170-1] DR ProteomicsDB; 297496; -. [P70170-2] DR ProteomicsDB; 297497; -. [P70170-3] DR ABCD; P70170; 5 sequenced antibodies. DR Antibodypedia; 12381; 261 antibodies from 31 providers. DR DNASU; 20928; -. DR Ensembl; ENSMUST00000073173.12; ENSMUSP00000072914.6; ENSMUSG00000030249.16. [P70170-3] DR Ensembl; ENSMUST00000087527.11; ENSMUSP00000084805.5; ENSMUSG00000030249.16. [P70170-1] DR Ensembl; ENSMUST00000100827.5; ENSMUSP00000098390.3; ENSMUSG00000030249.16. [P70170-2] DR Ensembl; ENSMUST00000205202.3; ENSMUSP00000144779.2; ENSMUSG00000030249.16. [P70170-3] DR GeneID; 20928; -. DR KEGG; mmu:20928; -. DR UCSC; uc009epm.1; mouse. [P70170-1] DR UCSC; uc009epo.1; mouse. [P70170-3] DR UCSC; uc009epp.1; mouse. [P70170-2] DR AGR; MGI:1352630; -. DR CTD; 10060; -. DR MGI; MGI:1352630; Abcc9. DR VEuPathDB; HostDB:ENSMUSG00000030249; -. DR eggNOG; KOG0054; Eukaryota. DR GeneTree; ENSGT00940000156680; -. DR HOGENOM; CLU_000604_27_4_1; -. DR InParanoid; P70170; -. DR OMA; WLSFWPR; -. DR OrthoDB; 3384185at2759; -. DR PhylomeDB; P70170; -. DR TreeFam; TF105201; -. DR Reactome; R-MMU-1296025; ATP sensitive Potassium channels. DR Reactome; R-MMU-382556; ABC-family proteins mediated transport. DR Reactome; R-MMU-5578775; Ion homeostasis. DR BioGRID-ORCS; 20928; 1 hit in 77 CRISPR screens. DR ChiTaRS; Abcc9; mouse. DR PRO; PR:P70170; -. DR Proteomes; UP000000589; Chromosome 6. DR RNAct; P70170; Protein. DR Bgee; ENSMUSG00000030249; Expressed in triceps brachii and 218 other cell types or tissues. DR ExpressionAtlas; P70170; baseline and differential. DR GO; GO:0001669; C:acrosomal vesicle; ISO:MGI. DR GO; GO:0008282; C:inward rectifying potassium channel; ISO:ComplexPortal. DR GO; GO:0016020; C:membrane; IBA:GO_Central. DR GO; GO:0005886; C:plasma membrane; IDA:MGI. DR GO; GO:0030017; C:sarcomere; IDA:MGI. DR GO; GO:0030315; C:T-tubule; ISO:MGI. DR GO; GO:0140359; F:ABC-type transporter activity; IEA:InterPro. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro. DR GO; GO:0019829; F:ATPase-coupled monoatomic cation transmembrane transporter activity; ISO:MGI. DR GO; GO:0042626; F:ATPase-coupled transmembrane transporter activity; ISO:MGI. DR GO; GO:1901363; F:heterocyclic compound binding; ISO:MGI. DR GO; GO:0042802; F:identical protein binding; ISO:MGI. DR GO; GO:0005267; F:potassium channel activity; IEA:Ensembl. DR GO; GO:0015459; F:potassium channel regulator activity; ISO:MGI. DR GO; GO:0008281; F:sulfonylurea receptor activity; ISO:MGI. DR GO; GO:0019905; F:syntaxin binding; ISO:MGI. DR GO; GO:0044325; F:transmembrane transporter binding; ISO:MGI. DR GO; GO:0001508; P:action potential; IMP:MGI. DR GO; GO:0001568; P:blood vessel development; IMP:MGI. DR GO; GO:0061337; P:cardiac conduction; ISO:MGI. DR GO; GO:0086003; P:cardiac muscle cell contraction; IMP:MGI. DR GO; GO:0072359; P:circulatory system development; IMP:MGI. DR GO; GO:0060976; P:coronary vasculature development; IGI:MGI. DR GO; GO:0051607; P:defense response to virus; ISO:MGI. DR GO; GO:0048144; P:fibroblast proliferation; IGI:MGI. DR GO; GO:0003007; P:heart morphogenesis; IMP:MGI. DR GO; GO:0098662; P:inorganic cation transmembrane transport; ISO:MGI. DR GO; GO:0098655; P:monoatomic cation transmembrane transport; ISO:MGI. DR GO; GO:0045776; P:negative regulation of blood pressure; IMP:MGI. DR GO; GO:1990573; P:potassium ion import across plasma membrane; ISO:ComplexPortal. DR GO; GO:0071805; P:potassium ion transmembrane transport; ISO:MGI. DR GO; GO:0006813; P:potassium ion transport; ISO:MGI. DR GO; GO:0008217; P:regulation of blood pressure; IMP:MGI. DR GO; GO:0033198; P:response to ATP; IMP:MGI. DR GO; GO:0009410; P:response to xenobiotic stimulus; IGI:MGI. DR GO; GO:0055085; P:transmembrane transport; IBA:GO_Central. DR CDD; cd18591; ABC_6TM_SUR1_D1_like; 1. DR CDD; cd18602; ABC_6TM_SUR1_D2_like; 1. DR CDD; cd03290; ABCC_SUR1_N; 1. DR CDD; cd03288; ABCC_SUR2; 1. DR Gene3D; 1.20.1560.10; ABC transporter type 1, transmembrane domain; 2. DR Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 2. DR InterPro; IPR003593; AAA+_ATPase. DR InterPro; IPR011527; ABC1_TM_dom. DR InterPro; IPR036640; ABC1_TM_sf. DR InterPro; IPR003439; ABC_transporter-like_ATP-bd. DR InterPro; IPR017871; ABC_transporter-like_CS. DR InterPro; IPR000388; ABCC8/9. DR InterPro; IPR001475; ABCC9. DR InterPro; IPR047080; ABCC9_ATP-bd_dom1. DR InterPro; IPR027417; P-loop_NTPase. DR PANTHER; PTHR24223; ATP-BINDING CASSETTE SUB-FAMILY C; 1. DR PANTHER; PTHR24223:SF173; ATP-BINDING CASSETTE SUB-FAMILY C MEMBER 9; 1. DR Pfam; PF00664; ABC_membrane; 2. DR Pfam; PF00005; ABC_tran; 2. DR PRINTS; PR01094; SULFNYLUR2. DR PRINTS; PR01092; SULFNYLUREAR. DR SMART; SM00382; AAA; 2. DR SUPFAM; SSF90123; ABC transporter transmembrane region; 2. DR SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 2. DR PROSITE; PS50929; ABC_TM1F; 2. DR PROSITE; PS00211; ABC_TRANSPORTER_1; 2. DR PROSITE; PS50893; ABC_TRANSPORTER_2; 2. DR Genevisible; P70170; MM. PE 1: Evidence at protein level; KW Alternative splicing; ATP-binding; Direct protein sequencing; Glycoprotein; KW Membrane; Nucleotide-binding; Receptor; Reference proteome; Repeat; KW Transmembrane; Transmembrane helix; Transport. FT CHAIN 1..1546 FT /note="ATP-binding cassette sub-family C member 9" FT /id="PRO_0000093403" FT TOPO_DOM 1..30 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 31..51 FT /note="Helical; Name=1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00441" FT TOPO_DOM 52..72 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 73..93 FT /note="Helical; Name=2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00441" FT TOPO_DOM 94..101 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 102..122 FT /note="Helical; Name=3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00441" FT TOPO_DOM 123..132 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 133..153 FT /note="Helical; Name=4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00441" FT TOPO_DOM 154..167 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 168..188 FT /note="Helical; Name=5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00441" FT TOPO_DOM 189..301 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 302..322 FT /note="Helical; Name=6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00441" FT TOPO_DOM 323..348 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 349..369 FT /note="Helical; Name=7" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00441" FT TOPO_DOM 370..421 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 422..442 FT /note="Helical; Name=8" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00441" FT TOPO_DOM 443..453 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 454..474 FT /note="Helical; Name=9" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00441" FT TOPO_DOM 475..529 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 530..550 FT /note="Helical; Name=10" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00441" FT TOPO_DOM 551..569 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 570..590 FT /note="Helical; Name=11" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00441" FT TOPO_DOM 591..987 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 988..1008 FT /note="Helical; Name=12" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00441" FT TOPO_DOM 1009..1031 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 1032..1052 FT /note="Helical; Name=13" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00441" FT TOPO_DOM 1053..1124 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 1125..1145 FT /note="Helical; Name=14" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00441" FT TOPO_DOM 1146..1242 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 1243..1263 FT /note="Helical; Name=15" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00441" FT TOPO_DOM 1264..1546 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT DOMAIN 297..595 FT /note="ABC transmembrane type-1 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00441" FT DOMAIN 669..909 FT /note="ABC transporter 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00434" FT DOMAIN 991..1271 FT /note="ABC transmembrane type-1 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00441" FT DOMAIN 1309..1543 FT /note="ABC transporter 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00434" FT REGION 941..964 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 947..963 FT /note="Acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 702..709 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00434" FT BINDING 1343..1350 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00434" FT CARBOHYD 9 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 330 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT VAR_SEQ 636..670 FT /note="Missing (in isoform SUR2C)" FT /evidence="ECO:0000303|PubMed:8826984" FT /id="VSP_000059" FT VAR_SEQ 1505..1546 FT /note="SSIVDAGLVLVFSEGILVECDTGPNLLQHKNGLFSTLVMTNK -> HTILTA FT DLVIVMKRGNILEYDTPESLLAQEDGVFASFVRADM (in isoform SUR2B)" FT /evidence="ECO:0000303|PubMed:8798681" FT /id="VSP_000060" SQ SEQUENCE 1546 AA; 174239 MW; 91EEDFA2ECD9DBC2 CRC64; MSLSFCGNNI SSYNIYYGVL QNPCFVDALN LVPHVFLLFI TFPILFIGWG SQSSKVQIHH NTWLHFPGHN LRWILTFALL FVHVCEIAEG IVSDSHRASR HLHLFMPAVM GFVATTTSIV YYHNIETSNF PKLLLALFLY WVMAFITKTI KLVKYWQLGW GVSDLRFCIT GVMVILNGLL MAVEINVIRV RRYVFFMNPQ KVKPPEDLQD LGVRFLQPFV NLLSKATYWW MNTLIISAHR KPIDLKAIGK LPIAMRAVTN YVCLKEAYEE QKKKAADHPN RTPSIWLAMY RAFGRPILLS STFRYLADLL GFAGPLCISG IVQRVNEKTN TTREMFPETL SSKEFLENAH VLAVLLFLAL ILQRTFLQAS YYVTIETGIN LRGALLAMIY NKILRLSTSN LSMGEMTLGQ INNLVAIETN QLMWFLFLCP NLWAMPVQII MGVILLYNLL GSSALVGAAV IVLLAPIQYF IATKLAEAQK STLDYSTERL KKTNEILKGI KLLKLYAWEH IFCKSVEETR MKELSSLKTF ALYTSLSIFM NAAIPIAAVL ATFVTHAYAS GNNLKPAEAF ASLSLFHILV TPLFLLSTVV RFAVKAIISV QKLNEFLLSD EIGEDSWRAG EGTLPFESCK KHTGVQSKPI NRKQPGRYHL DSYEQARRLR PAETEDIAIK VTNGYFSWGS GLATLSNIDI RIPTGQLTMI VGQVGCGKSS LLLAILGEMQ TLEGKVYWNN VNESEPSFEA TRSRSRYSVA YAAQKPWLLN ATVEENITFG SPFNRQRYKA VTDACSLQPD IDLLPFGDQT EIGERGINLS GGQRQRICVA RALYQNTNIV FLDDPFSALD IHLSDHLMQE GILKFLQDDK RTVVLVTHKL QYLTHADWII AMKDGSVLRE GTLKDIQTKD VELYEHWKTL MNRQDQELEK DMEADQTTLE RKTLRRAMYS REAKAQMEDE DEEEEEEEDE EDNMSTVMRL RTKMPWKTCW WYLTSGGFFL LFLMIFSKLL KHSVIVAIDY WLATWTSEYS INHPGKADQT FYVAGFSILC GAGIFLCLVT SLTVEWMGLT AAKNLHHNLL NKIILGPIRF FDTTPLGLIL NRFSADTNII DQHIPPTLES LTRSTLLCLS AIGMISYATP VFLVALAPLG VAFYFIQKYF RVASKDLQEL DDSTQLPLLC HFSETAEGLT TIRAFRHETR FKQRMLELTD TNNIAYLFLS AANRWLEVRT DYLGACIVLT ASIASISGSS NSGLVGLGLL YALTITNYLN WVVRNLADLE VQMGAVKKVN SFLTMESENY EGTMDPSQVP EHWPQEGEIK IHDLCVRYEN NLKPVLKHVK AYIKPGQKVG ICGRTGSGKS SLSLAFFRMV DIFDGKIVID GIDISKLPLH TLRSRLSIIL QDPILFSGSI RFNLDPECKC TDDRLWEALE IAQLKNMVKS LPGGLDATVT EGGENFSVGQ RQLFCLARAF VRKSSILIMD EATASIDMAT ENILQKVVMT AFADRTVVTI AHRVSSIVDA GLVLVFSEGI LVECDTGPNL LQHKNGLFST LVMTNK //